Article
type: Class

Document
type: Class

http://irises.unibs.it/resource/item/146325
type: Entity
type: Academic Article
type: Article
type: Document
language: Inglese
most specific type: Academic Article
type: Thing
label: Postremission therapy with repeated courses of high-dose cytarabine, idarubicin, and limited autologous stem cell support achieves a very good long-term outcome in European leukemia net favorable and intermediate-risk acute myeloid leukemia
type: Generically Dependent Continuant
type: Continuant
type: Information Content Entity

Information Content Entity
type: Class

Academic Article
type: Class

Continuant
type: Class

Inglese
type: Language

Entity
type: Class

Generically Dependent Continuant
type: Class

individual
rights: termsOfUse
date: 2026-08-25T22:11:01
publisher: http://irises.unibs.it/resource/item/146325
type: Document
label: RDF description of Postremission therapy with repeated courses of high-dose cytarabine, idarubicin, and limited autologous stem cell support achieves a very good long-term outcome in European leukemia net favorable and intermediate-risk acute myeloid leukemia - http://irises.unibs.it/resource/item/146325